Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EY
Corgi Data & Surveillance ETF
EYES
Volume
775
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EY
EYES
EY
Corgi Data & Surveillance ETF
EYES
News
·
Palantir's Growth Story Gets a Goldman Boost: ETFs to Consider
AUM
N/A
Volume
775
Yield
N/A
Chart
Financials
Earnings
News
About
Insider
Filings
Palantir's Growth Story Gets a Goldman Boost: ETFs to Consider
Goldman Sachs upgraded Palantir Technologies to Buy with a $230 price target, citing potential for outperformance through 2027 driven by sovereign AI and verticalization strategy. Dan Ives also included Palantir in his top five tech picks for 2027, with a $250 price target, as the market underappreciates the $4 trillion AI spending boom. The stock has surged 58% since mid-2026.
Zacks Investment Research · Oct 9, 2026
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk, which pioneered GLP-1 weight-loss drugs but lost market leadership to Eli Lilly, is attempting a comeback through product innovation. The company has launched a pill version of Wegovy and partnered with Vivani Medical to develop an implant that could deliver the drug once or twice yearly, potentially revolutionizing convenience in the GLP-1 market. While Eli Lilly maintains a stronger market position and higher valuation, Novo Nordisk's continued innovation could help it regain competitive ground.
The Motley Fool · Aug 29, 2026
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
EmergingGrowth.com announces the 94th Emerging Growth Conference scheduled for July 15-16, 2026, featuring presentations from 20+ small-cap and emerging growth companies across sectors including mining, technology, healthcare, and renewable energy. The virtual conference allows companies to present their strategies, products, and announcements to the investment community.
GlobeNewswire Inc. · Jul 14, 2026
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Vivani Medical announced a definitive merger agreement to merge its wholly owned subsidiary Cortigent, Inc. with ClearOne, Inc. Under the transaction, Cortigent will become a wholly owned subsidiary of ClearOne, which will be renamed Cortigent Holdings, Inc. and trade under ticker symbol 'CRGT'. ClearOne will raise $10-15 million in concurrent financing. Vivani will receive 12.5 million shares and own 59.4-67.5% of the combined company. The transaction is expected to close in Q3 2026.
GlobeNewswire Inc. · Jul 2, 2026
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares gained 80.2% to close at $0.91 after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency. Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA) jumped 48.3% to settle at $14.07 following the completion of the SPAC merger with Akili. Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 40.4% to close at $59.55 after the company announced the U.S. FDA has approved Auvelity for the treatment of major depressive disorder in adults. Lottery.com Inc. (NASDAQ: LTRY) gained 31.8% to settle at $0.48. Volcon, Inc. (NASDAQ: VLCN) rose 31.5% to settle at $2.42 after the company announced it has received over $100 million of pre-production orders for the Stag. Greenbrook TMS Inc. (NASDAQ: GBNH) gained 29.5% to close at $3.07. Greenbrook TMS recently posted Q2 loss of $0.41 per share. Graphex Group Limited (NYSE: GRFX) jumped 21.4% to close at $2.50. Graphex Group announced closing of upsized $11.7 million public offering and NYSE American listing. Immunovant, Inc. (NASDAQ: IMVT) gained 21.1% to settle at $6.21. Foot Locker, Inc. (NYSE: FL) climbed 20% to close at $38.39 after the company reported Q2 results and announced a CEO transition. B of A Securities and Citigroup upgraded their ratings on the stock. T Stamp Inc. (NASDAQ: IDAI) gained 19.9% to settle at $1.75. Aditxt, Inc. (NASDAQ: ADTX) gained 18.5% to settle at $0.19. Assure Holdings Corp. (NASDAQ: IONM) climbed 17.7% to close at $1.40. Assure Hldgs recently posted Q2 loss of $0.37 per share. Bill.com Holdings, Inc. (NYSE: BILL) shares jumped 16.7% to close at $174.29 after the company announced better-than-expected Q4 results and issued sales guidance above estimates. Bionomics Limited (NASDAQ: BNOX) rose 16.2% to close at $8.15. Taylor Devices, Inc. (NASDAQ: TAYD) gained 16.1% to settle at $9.81 after reporting a sharp rise in Q4 earnings. Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 14.2% to close at $4.11. Applied DNA submitted PCR-based Monkeypox virus diagnostic test for approval to New York State Department of Health. Regis Corporation (NYSE: RGS) gained 13.8% to close at $1.57. Mannatech, Incorporated (NASDAQ: MTEX) surged 12.8% to settle at $26.50. Mannatech recently reported a second-quarter FY22 sales decline of 17.7% year-on-year, to $35 million, compared to $42.5 million. Secoo Holding Limited (NASDAQ: SECO) jumped 11.3% to close at $0.2650 following announcement of equity investment led by private equity firm HCYK. Bruush Oral Care Inc. (NASDAQ: BRSH) gained 11.3% to settle at $2.36. Avaya Holdings Corp. (NYSE: AVYA) rose 11.2% to close at $0.7246. Avaya recently received New York Stock Exchange notice regarding late form 10-Q filing. Summit Therapeutics Inc. (NASDAQ: SMMT) shares gained 10% to close at $1.10. Summit Therapeutics CEO Robert W Duggan acquired a total of 94,849,203 shares at an average price of $0.97. Occidental Petroleum Corporation (NYSE: OXY) ...
Benzinga · Aug 22, 2022
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. Volcon, Inc. (NASDAQ: VLCN) gained 51% to $2.7899 after the company announced it has received over $100 million of pre-production orders for the Stag Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares jumped 41.2% to $0.7131 after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency. Axsome Therapeutics, Inc. (NASDAQ: AXSM) gained 41% to $59.84 after the company announced the U.S. FDA has approved Auvelity for the treatment of major depressive disorder in adults. Summit Therapeutics Inc. (NASDAQ: SMMT) shares rose 28.8% to $1.2875. Summit Therapeutics CEO Robert W Duggan acquired a total of 94,849,203 shares at an average price of $0.97. TDH Holdings, Inc. (NASDAQ: PETZ) shares climbed 25.3% to $3.7350. TDH Holdings acquired 100% of the equity interests of Beijing Wenxin Company., Ltd. Assure Holdings Corp. (NASDAQ: IONM) rose 23.3% to $1.47. Assure Hldgs recently posted Q2 loss of $0.37 per share. Foot Locker, Inc. (NYSE: FL) gained 21.2% to $38.76 after the company reported Q2 results and announced a CEO transition. B of A Securities and Citigroup upgraded their ratings on the stock. Taylor Devices, Inc. (NASDAQ: TAYD) rose 21.2% to $10.23 after reporting a sharp rise in Q4 earnings. Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 20.4% to $1.5530 after the company reported Q2 year over year sales growth of 273%. Bill.com Holdings, Inc. (NYSE: BILL) shares climbed 17% to $174.76 after the company announced better-than-expected Q4 results and issued sales guidance above estimates. Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 16% to $4.1769. Applied DNA submitted PCR-based Monkeypox virus diagnostic test for approval to New York State Department of Health. Endo International plc(NASDAQ: ENDP) rose 15.2% to $0.4675 after jumping 43% on Thursday. Endo International recently filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits. SaverOne 2014 Ltd (NASDAQ: SVRE) gained 14.6% to $2.99. Cybin ...
Benzinga · Aug 19, 2022
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday. Eargo, Inc. (NASDAQ: EAR) shares rose 148% to $1.74 in pre-market trading. The company is scheduled to report Q2 earnings on Monday, August 8. Applied DNA Sciences, Inc. (NASDAQ: APDN) shares rose 63% to $4.57 in pre-market trading after jumping 297% on Tuesday. Applied DNA Sciences initiated analytical validation of a company-developed, PCR-based monkeypox virus test specific to the genetic signature of the monkeypox virus. Tuniu Corporation (NASDAQ: TOUR) shares rose 61% to $1.30 in pre-market trading after dropping over 9% on Tuesday. Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 52.1% to $1.11 in pre-market trading. Chembio Diagnostics is expected to release financial results for the second quarter after the close of trading on Thursday, August 4, 2022. AMTD IDEA Group (NYSE: AMTD) rose 35% to $9.46 in pre-market trading after jumping over 236% on Tuesday. MediaCo Holding Inc. (NASDAQ: MDIA) rose 35% to $5.14 in pre-market trading after climbing around 14% on Tuesday. Standard General recently purchased roughly 12.9 million shares, bringing ownership to 92.4%. SemiLEDs Corporation (NASDAQ: LEDS) rose 32% to $4.30 in pre-market trading. Otonomy, Inc. (NASDAQ: OTIC) rose 28.8% to $0.3213 in pre-market trading. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints. Connexa Sports Technologies Inc. (NASDAQ: CNXA) rose 26.8% to $1.37 in pre-market trading after jumping 20% on Tuesday. Ocean Power Technologies, Inc. (NASDAQ: OPTT) rose 23.3% to $1.27 in pre-market trading after surging 10% on Tuesday. Talis Biomedical Corporation (NASDAQ: TLIS) rose 23% to $0.94 in pre-market trading after reporting a sharp rise in Q2 sales. Crawford & Company (NYSE: ...
Benzinga · Aug 3, 2022
Boeing And 24 Stocks Moving Premarket
Gainers Qudian Inc. (NYSE: QD) rose 61.3% to $1.92 in pre-market trading after the company issued an update on its QD Food ready-to-cook meal business. AMTD Digital Inc. (NYSE: HKD) rose 40% to $22.70 in pre-market trading after gaining 108% on Friday. The company priced its IPO at $7 per share. ITHAX Acquisition Corp. (NASDAQ: ITHX) rose 31.4% to $18.39 in pre-market trading after jumping over 40% on Friday. ITHAX Acquisition’s shareholders approved business combination with Mondee. Intelligent Living Application Group Inc. (NASDAQ: ILAG) rose 25.8% to $2.83 in pre-market trading after declining 11% on Friday. The company reported closing of $20.24 million initial public offering. Vertical Aerospace Ltd. (NASDAQ: EVTL) rose 17% to $5.85 in pre-market trading. Vertical Aerospace shares jumped 72% on Friday after the company announced FLYINGGROUP has conditionally pre-ordered up to 50 VX4 aircrafts. LumiraDx Limited (NASDAQ: LMDX) rose 16.2% to $2.73 in pre-market trading after dropping around 10% on Friday. LumiraDx, last month, announced it achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete. SunLink Health Systems, Inc. (NASDAQ: SSY) rose 13% to $1.13 in pre-market trading. SunLink ...
Benzinga · Jul 18, 2022
3 Stocks Under $3 Insiders Are Aggressively Buying
The Federal Open Market Committee opted to raise fed funds rates by 0.75% on Wednesday to a new target range of between 1.5% and 1.75%. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3 HCW Biologics The Trade: HCW Biologics Inc. (NASDAQ: HCWB) Chief Financial Officer Rebecca Byam acquired a total of 66,452 shares at ...
Benzinga · Jun 16, 2022
3 Stocks Under $3 Insiders Are Aggressively Buying
US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3 Second Sight Medical Products The Trade: Second Sight Medical Products, Inc. (NASDAQ: EYES) Director Gregg Williams acquired a total of 312,493 shares at an average price of $2.30. To ...
Benzinga · Jun 3, 2022
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
EY
EYES
Corgi Data & Surveillance ETF
Buy
Sell
Market
Limit
Soon
EYES
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any EYES yet.
Related Tickers
Earnings